Newswise — ANN ARBOR, Michigan — Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Technology24 hours ago
Best Buy US has some sweet Cyber Week deals – GSMArena.com news – GSMArena.com
Business21 hours ago
Are Bank of Queensland (ASX:BOQ) shares really going to pay a 10% dividend yield?
General19 hours ago
Cairns quarantine hotel blaze prompts emergency declaration
Stanthorpe News16 hours ago
Qld’s December 17 reopening on track, despite new Omicron threat